Treace John T. - 22 Jan 2025 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Lisa Taylor as Attorney-in-fact for John Treace
Issuer symbol
TMCI
Transactions as of
22 Jan 2025
Net transactions value
$0
Form type
4
Filing time
24 Jan 2025, 21:30:04 UTC
Previous filing
14 Jan 2025
Next filing
04 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMCI Common Stock Award $0 +225,000 +3.5% $0.000000 6,736,190 22 Jan 2025 Direct F1, F2
holding TMCI Common Stock 1,605,000 22 Jan 2025 By spouse F3
holding TMCI Common Stock 1,471,250 22 Jan 2025 By spouse as trustee of a trust F3
holding TMCI Common Stock 1,839,063 22 Jan 2025 As trustee of a trust F4
holding TMCI Common Stock 408,816 22 Jan 2025 As co-trustee of a trust F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 22, 2026 and the last installment vesting on January 22, 2029; subject to Reporting Person's providing continued service to Issuer through each vesting date.
F2 Includes 437,536 restricted stock units
F3 The Reporting Person disclaims beneficial ownership of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee
F4 The Reporting Person disclaims beneficial ownership of shares held in trust for which he serves as trustee or co-trustee.